Product Images Advair Diskus

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 18 images provide visual information about the product associated with Advair Diskus NDC 54868-4518 by Physicians Total Care, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 2. Mean Percent Change From Baseline in FEV1 in Patients With Asthma Previously Treated With Either Inhaled Corticosteroids or Salmeterol (Study 1) - 1fd31ab8 8175 47ea 8495 065313f1ea1e 01

Figure 2. Mean Percent Change From Baseline in FEV1 in Patients With Asthma Previously Treated With Either Inhaled Corticosteroids or Salmeterol (Study 1) - 1fd31ab8 8175 47ea 8495 065313f1ea1e 01

Figure 3. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - 1fd31ab8 8175 47ea 8495 065313f1ea1e 02

Figure 3. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - 1fd31ab8 8175 47ea 8495 065313f1ea1e 02

This is a description of a medication called "ADVAIR DSKIS 100/E0" which contains "Futasone prpitat" and comes in a package size of 35. The text also displays some numerical values, perhaps related to dosage or usage instructions. The last line says "Baseline", which is not enough context to determine its meaning.*

Figure 4. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - 1fd31ab8 8175 47ea 8495 065313f1ea1e 03

Figure 4. Percent Change in Serial 12-hour FEV1 in Patients With Asthma Previously Using Either Inhaled Corticosteroids or Salmeterol (Study 1) - 1fd31ab8 8175 47ea 8495 065313f1ea1e 03

Figure 5. Predose FEV1: Mean Percent Change From Baseline in Patients With Chronic Obstructive Pulmonary Disease - 1fd31ab8 8175 47ea 8495 065313f1ea1e 04

Figure 5. Predose FEV1: Mean Percent Change From Baseline in Patients With Chronic Obstructive Pulmonary Disease - 1fd31ab8 8175 47ea 8495 065313f1ea1e 04

Figure 6. Two-Hour Postdose FEV1: Mean Percent Changes From Baseline Over Time in Patients With Chronic Obstructive Pulmonary Disease - 1fd31ab8 8175 47ea 8495 065313f1ea1e 05

Figure 6. Two-Hour Postdose FEV1: Mean Percent Changes From Baseline Over Time in Patients With Chronic Obstructive Pulmonary Disease - 1fd31ab8 8175 47ea 8495 065313f1ea1e 05

This appears to be a table comparing the effectiveness of three different treatments - ADVAIR DISKUS 25050, Fluticasone Propionalis 2501, and Placebo - based on FEV (forced expiratory volume). The table includes numerical data in the form of baseline FEV measurements, and treatment effectiveness measurements at various time intervals.*

Diskus parts - 1fd31ab8 8175 47ea 8495 065313f1ea1e 06

Diskus parts - 1fd31ab8 8175 47ea 8495 065313f1ea1e 06

This text refers to the different parts or components of a device, possibly a medical or pharmaceutical, that may include a lever, a mouthpiece, a dose indicator, a thumb grip or Thumbarip, and an outer case. The purpose and function of the device cannot be determined solely from this information.*

Figure 1 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 07

Figure 1 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 07

Figure 2 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 08

Figure 2 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 08

Figure 3 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 09

Figure 3 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 09

Figure 4 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 10

Figure 4 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 10

Figure 5 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 11

Figure 5 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 11

Figure 6 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 12

Figure 6 - 1fd31ab8 8175 47ea 8495 065313f1ea1e 12

Figure 1. Cumulative Incidence of Asthma-Related Deaths in the 28-Week Salmeterol Multi-center Asthma Research Trial (SMART), by Duration of Treatment - 1fd31ab8 8175 47ea 8495 065313f1ea1e 16

Figure 1. Cumulative Incidence of Asthma-Related Deaths in the 28-Week Salmeterol Multi-center Asthma Research Trial (SMART), by Duration of Treatment - 1fd31ab8 8175 47ea 8495 065313f1ea1e 16

fluticasone propionate chemical structure - 1fd31ab8 8175 47ea 8495 065313f1ea1e 17

fluticasone propionate chemical structure - 1fd31ab8 8175 47ea 8495 065313f1ea1e 17

salmeterol xinafoate chemical structure - 1fd31ab8 8175 47ea 8495 065313f1ea1e 18

salmeterol xinafoate chemical structure - 1fd31ab8 8175 47ea 8495 065313f1ea1e 18

100/50 PDP - package label 01

100/50 PDP - package label 01

This is a prescription inhaler medication called Advair Diskus, which is distributed by Physicians Total Care. It has a strength of 160/50. The lot number is 6060 and the expiration date is 01760. No further information is available.*

250/50 PDP - package label 02

250/50 PDP - package label 02

This is a description of a medication called Advair Diskus inhaler, with a strength of 25e/5e. The medication is distributed by Physicians Total Care and has an NDC code of 54868-4517-0. The lot number is not entirely legible, but the expiration date is 01760. The rest of the text is not readable and could not be used to generate a useful description.*

500/50 PDP - package label 03

500/50 PDP - package label 03

DIST. BY: PHYSICIANS TOTAL CARE is the distributor information for a medication called ADVAIR DISKUS INHALER 506/50. The medication's National Drug Code (NDC) is 54868-4516-8 and its Lot number is 6000 with an expiration date of €1/60. The rest of the text is not readable.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.